Novakivskyy, V. (2017). PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR: HEMODIALYSIS VSHEMODIAFILTRATION. State Institution «Institute of Nephrology NAMS of Ukraine".
Chicago Style (17th ed.) CitationNovakivskyy, V. PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR: HEMODIALYSIS VSHEMODIAFILTRATION. State Institution «Institute of Nephrology NAMS of Ukraine", 2017.
MLA (8th ed.) CitationNovakivskyy, V. PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR: HEMODIALYSIS VSHEMODIAFILTRATION. State Institution «Institute of Nephrology NAMS of Ukraine", 2017.
Warning: These citations may not always be 100% accurate.